After Lonza announced the collaboration with Ethris to develop spray-dried mRNA vaccines for Respiratory Disease Prevention, EPM spoke to Carsten Rudolph, co-founder, Ethris and Kim Shepard, director of advanced drug delivery at Lonza to learn more.
In order to limit the devastating effects of global warming and climate change, the UK has legally committed to reaching net zero by 2050, meaning that greenhouse gas (GHG) emissions will be equal to the emissions removed from the atmosphere.
In pharmaceutical manufacturing, both sterility and uninterrupted operations are essential – this poses challenges when it comes to component monitoring.
Rohit Dayama, global client partner, Life Sciences, UK&I, Cognizant explores how by harnessing extensive datasets, organisations can speed up drug discovery, refine precision medicine, and improve operational efficiency.
James Kennedy, technology analyst at IDTechEx, explores how the global shift away from fossil-based systems is driving momentum for the bioeconomy as a more sustainable and circular alternative.
Scotland’s life sciences sector is a crucial part of the nation’s economy, contributing innovation in areas such as biotechnology, pharmaceuticals, and vaccine manufacture. Jeanette Rigby, director human resources at Valneva Scotland, discusses.
For manufacturers facing production challenges, renting product inspection systems can be a cost-effective, flexible solution. Christine Gottschalk, head of PI Test and Demo Center at Mettler-Toledo, discusses the benefits of rental technologies.
August 2025 marks two years since revisions to Annex 1 of the European Union’s Good Manufacturing Practice (GMP) guidelines were introduced. Niamh Bissett, director, business transformation at West Pharmaceutical Services discusses.
Sail Biomedicines’ Kerry Benenato and Rajesh Ramaswamy discuss the roles artificial intelligence (AI) can play in informing programmability, using the example of Sail’s tailored Endless RNATM (eRNATM) medicines.
